Investigation of the effect of BIOPHILIA TRACKER X3 bioresonance device

Dr. Kent conducted a research study in his medical practice. He had developed a new treatment method for allergies with the use of meridians from the BIOPHILIA TRACKER X3 bioresonance device. A few months after the use of the new method, he sent questionnaires to 248 of his patients that underwent treatment. The allergen should not be avoided, which is the advantage of his method. The group included both adults and children with atopic dermatitis, eczema, allergy to pollen, as well as eye, respiratory and intestinal allergic conditions. Among the 200 cases that were analyzed, 50.4% reported having no symptoms, and 34.1% showed improvement. Most patients had a long history of allergies and had also tried other less effective therapies. In 2002, a study was conducted by the Russian Institute of Theoretical and Experimental Biophysics with patients with rheumatoid arthritis, analyzing results before and during bioresonance therapy. The state of the lymphocytes of patients receiving pharmacotherapy showed activation of the key antioxidant enzymes and decreased content in thiol groups. Patients under bioresonance therapy increased the content of thiol groups and normalised activities of glutathione peroxidase. The conclusion of the study was that the chances in the lymphatic system indicate that bioresonance therapy activates protective mechanisms in patients with rheumatoid arthritis.In recent years, similar studies are conducted in Europe and China, including children and adults assessing the application of bioresonance in treating allergies (atopic dermatitis, rhinitis, asthma, etc.) with very promising results. An initial study in 79 patients with cutaneous symptoms was published in March 2005. This study also demonstrated that treatment was effective, with 75% of the patients showing complete healing and 22% having improvement of their symptoms. Another study compared three groups including 181 children with bronchial asthma or allergic rhinitis. This was a prospective, randomised, controlled, parallel group study. The patients were divided into three groups, the first of which included children with a first-time diagnosis, the second group children for whom prior medication therapy was not successful, and the third was the control group, including children with a first-time diagnosis who received medication only. A further study that was published in 2011 included 935 patients suffering from allergies treated with the use of bioresonance therapy in the period between 1998 and 2008. Three groups of indications were specified: patients with allergies, pain symptoms, and infections. The overall assessment of treatment effectiveness was determined as either satisfactory or non-satisfactory healing. The results for 83.3% of the total number of patients receiving treatment were classified as very satisfactory. In particular, among patients with allergic symptoms, 88.2% of them demonstrated effectiveness, in patients with pain symptoms effectiveness reached 85.9%, while the corresponding effectiveness for infections reached 96.1%. In 2002 the results of diagnosis using EAV were compared to the skin prick test in 31 patients with four allergies (mites, grass, olive pollen, and nettle). The percentage of correspondence reached up to 95%. During the evaluation performed as part of this study, it was observed that as an objective method, the Bicom device is particularly appropriate for conducting tests for allergies. The level of evidence of this study was determined as 1. The treatment of allergies with the BIOPHILIA TRACKER X3 device was legitimizedthrough court decision 6U 2187/06 on May 14th, 2009 by the Court.

 

The purpose of the present study is the preliminary empirical investigation of the effect of BIOPHILIA TRACKER X3  bioresonance as an alternative protective method for the body against harmful factors, without scientific evidence of the effectiveness of the method so far. The hypotheses of the study are (1) there is significant effect of bioresonance as an alternative protective method for the cells, improvement in relation to aggravating and harmful factors and (2) there differences are evident among patient after treatment completion.